These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4223693)

  • 1. Interactions of epsilon-aminocaproic acid with the thrombin clotting and fibrinolytic systems.
    Maxwell RE; Allen D
    Nature; 1966 Jan; 209(5019):211-3. PubMed ID: 4223693
    [No Abstract]   [Full Text] [Related]  

  • 2. INTRAVASCULAR CLOTTING AND SPONTANEOUS FIBRINOLYSIS.
    KOLLER F
    Acta Haematol; 1964 Apr; 31():239-46. PubMed ID: 14169390
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of heparin and epsilon-aminocaproic acid in dogs on plasmin-125-I generation in response to urokinase injections and venous injury.
    Takeda Y; Parkhill TR; Nakabayashi M
    J Clin Invest; 1972 Oct; 51(10):2678-85. PubMed ID: 4262519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the mechanism of action of inhibitors of the fibrinolysin system.
    Ambrus CM; Ambrus JL; Lassman HB; Mink IB
    Ann N Y Acad Sci; 1968 Jun; 146(2):430-47. PubMed ID: 4239437
    [No Abstract]   [Full Text] [Related]  

  • 5. ACTIVATION OF THE BLOOD FIBRINOLYTIC ENZYME SYSTEM BY PLATELETS.
    REID WO; SILVER MJ
    Am J Physiol; 1964 Jun; 206():1255-61. PubMed ID: 14191030
    [No Abstract]   [Full Text] [Related]  

  • 6. Biological activities of leupeptins.
    Aoyagi T; Miyata S; Nanbo M; Kojima F; Matsuzaki M
    J Antibiot (Tokyo); 1969 Nov; 22(11):558-68. PubMed ID: 4243683
    [No Abstract]   [Full Text] [Related]  

  • 7. THE INHIBITION OF TRASYLOL OF FIBRINOLYTIC ACTIVITY ASSOCIATED WITH CARDIOVASCULAR OPERATIONS.
    TICE DA; WORTH MH; CLAUSS RH; REED GH
    Surg Gynecol Obstet; 1964 Jul; 119():71-4. PubMed ID: 14179354
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of inhibitory effect of epsilon-aminocaproic acid on the activation process of human and bovine plasminogen.
    Onishi T; Muramatu M; Sato T; Fujii S
    J Biochem; 1966 Jul; 60(1):87-9. PubMed ID: 5912938
    [No Abstract]   [Full Text] [Related]  

  • 9. Anticoagulant and thrombolytic drugs. I. Patho-physiological and pharmacological aspects.
    Ogston D; Douglas AS
    Drugs; 1971; 1(3):228-46. PubMed ID: 4256645
    [No Abstract]   [Full Text] [Related]  

  • 10. Study of mechanisms which preserve blood fluidity and the effect of their inhibition on thrombogenesis.
    Gans H
    J Surg Res; 1966 Feb; 6(2):87-92. PubMed ID: 4221774
    [No Abstract]   [Full Text] [Related]  

  • 11. STUDY OF FIBRINOGEN TURNOVER RATES AFTER TOTAL HEPATECTOMY IN DOGS.
    GANS H
    Surgery; 1964 Apr; 55():544-50. PubMed ID: 14138019
    [No Abstract]   [Full Text] [Related]  

  • 12. Improved method for measuring fibrinogen in plasma, with use of a plasmin inhibitor.
    Steffen LW; Steffen BW
    Clin Chem; 1976 Mar; 22(3):381-3. PubMed ID: 130214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STUDIES ON THE MOLECULAR PATHOLOGY AND PATHOGENESIS OF BLEEDING IN SEVERE FIBRINOLYTIC STATES IN DOGS.
    KOWALSKI E; BUDZYNSKI AZ; KOPEC M; LATALLO ZS; LIPINSKI B; WEGRZYNOWICZ Z
    Thromb Diath Haemorrh; 1964 Oct; 12():69-86. PubMed ID: 14224647
    [No Abstract]   [Full Text] [Related]  

  • 14. ACTION OF THE NEW ANTI-FIBRINOLYTIC SUBSTANCE ON THE STREPTOKINASE-ACTIVATED PROTEASES (PLASMINS).
    MIHARA H
    Kobe J Med Sci; 1963 Dec; 18():169-77. PubMed ID: 14160537
    [No Abstract]   [Full Text] [Related]  

  • 15. THERMOSTABLE ANTICOAGULANT FROM THE ANTICOAGULANT FRACTION OF INCUBATED FIBRINOGEN.
    TRIANTAPHYLLOPOULOS E; TRIANTAPHYLLOPOULOS DC
    Br J Haematol; 1965 May; 11():331-41. PubMed ID: 14282070
    [No Abstract]   [Full Text] [Related]  

  • 16. A COAGULATION ANOMALY: PLASMA BEING MADE NON-CLOTTABLE BY ADDING THROMBIN, AND CLOTTABLE BY THROMBOPLASTIN-CALCIUM OR TOLUIDINE BLUE-THROMBIN.V5 BLUE-THROMBIN.
    MAKI M; KIKUCHI K; WATANABE S; KIKUCHI E
    Tohoku J Exp Med; 1964 Dec; 84():274-81. PubMed ID: 14244484
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombin and acetylated thrombin in the activation of fibrinolysis.
    Landaburu RH; Giavedoni E; Santillán R
    Can J Physiol Pharmacol; 1968 Nov; 46(6):809-13. PubMed ID: 5698925
    [No Abstract]   [Full Text] [Related]  

  • 18. [Inhibition of blood coagulation in vitro by protease of Pseudomonas aeruginosa].
    Scharmann W; Kraft W
    Blut; 1974 Feb; 28(2):90-9. PubMed ID: 4272950
    [No Abstract]   [Full Text] [Related]  

  • 19. EFFECT OF PLASMIN ON FIBRINOGEN AND FIBRIN.
    GAJEWSKI J; ALEXANDER B
    Am J Physiol; 1964 Jan; 206():79-82. PubMed ID: 14111457
    [No Abstract]   [Full Text] [Related]  

  • 20. ROLE OF PLATELET FIBRINOGEN IN THE REACTIONS OF PLATELETS TO THROMBIN.
    MORSE EE; JACKSON DP; CONLEY CL
    J Clin Invest; 1965 May; 44(5):809-16. PubMed ID: 14276138
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.